PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Vaccine Clinical Evaluation, Jiangsu Province Center for Disease Control and Prevention, Nanjing, China.\', \'NHC Key laboratory of Enteric Pathogenic Microbiology, Nanjing, China.\', \'Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, China.\', \'Department of Vaccine Clinical Evaluation, Jiangsu Province Center for Disease Control and Prevention, Nanjing, China. jszfc@vip.sina.com.\', \'NHC Key laboratory of Enteric Pathogenic Microbiology, Nanjing, China. jszfc@vip.sina.com.\', \'Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, China. jszfc@vip.sina.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41392-021-00481-y
?:doi
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 33531462
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all